| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.2 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.5 |